Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis
Advanced Science · 2025
DOI: 10.1002/advs.202500028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Dahe Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao…. Hauptthemen laut MEDLINE: Osteoarthritis, Temporomandibular Joint Disorders, Cartilage, Articular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai's Top Priority Research Center, National Key R&D Program of China.
Abstract (Originalsprache)
Temporomandibular joint osteoarthritis (TMJOA) is one of the most complex temporomandibular disorders. Cartilage matrix degradation results in the infiltration of nerves, blood vessels, and inflammatory cells, which disrupts chondrocyte function. Therapeutic strategies for TMJOA designed to maintain cartilage homeostasis remain largely unknown. Here, it is reported that orosomucoid 1 (ORM1) attenuated TMJOA progression by maintaining cartilage homeostasis. It is demonstrated that ORM1 is down‐regulated in the synovial fluid of patients with TMJOA and condylar cartilage of unilateral anterior crossbite (UAC) rats. Administration of ORM1 protein significantly inhibited cartilage matrix degradation and alleviated TMJOA progression in UAC rats. At the mechanistic level, ORM1 binds to vimentin (VIM), a type III intermediate filament cytoskeletal protein, and inhibits the mitogen‐activated protein kinase (MAPK) pathway, thereby significantly decreasing cartilage matrix degradation mediated through inhibiting the cartilage degradation markers matrix metalloproteinase 13 (MMP13) and MMP3, and maintaining cartilage homeostasis. Notably, inhibition of VIM in vivo also markedly improved TMJOA progression, including cartilage degradation and subchondral bone destruction. In conclusion, these findings demonstrate the important functions of ORM1 in maintaining cartilage homeostasis via suppressing VIM/MAPK/MMP signaling and suggest that ORM1 is a promising target for therapeutic intervention in TMJOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical R…
ORCID-Profile: Chi Yang
Förderung
- National Natural Science Foundation of China
- Shanghai's Top Priority Research Center
- National Key R&D Program of China
- Science and Technology Commission of Shanghai Municipality
- Biological Sample Project of Dominant Diseases, the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine
- Natural Science Foundation of Shanghai
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Zhang, D., Zhang, Y., Xia, S., Chen, L., Shen, P., & Yang, C. (2025). Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis. Advanced Science. https://doi.org/10.1002/advs.202500028
Vancouver
Zhang D, Zhang Y, Xia S, Chen L, Shen P, Yang C. Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis. Advanced Science. 2025. doi:10.1002/advs.202500028
BibTeX
@article{Zhang2025,
author = {Zhang, Dahe and Zhang, Yuxin and Xia, Simo and Chen, Lu and Shen, Pei and Yang, Chi},
title = {Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500028}
}
EUVIMED